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Abstract
We developed transgenic (Tg) mice modeling an autosomally inherited mitochondrial disease, chronic progressive external
ophthalmoplegia, patients with which sometimes have comorbid mood disorders. The mutant animals exhibited bipolar
disorder-like phenotypes, such as a distorted day–night rhythm and a robust activity change with a period of 4–5 days, and
the behavioral abnormalities were improved by lithium. In this study, we tested the effect of electroconvulsive stimulation
(ECS) on the behavioral abnormalities of the model. Electroconvulsive therapy, which has long been used in clinical practice,
provides fast-acting relief to depressive patients and drug-resistant patients. We performed long-term recordings of wheel-
running activity of Tg and non-Tg mice. While recording, we administrated a train of ECS to mice, six times over two weeks
or three times over a week. The treatment ameliorated the distorted day–night rhythm within three times of ECS, but it had
no effect on the activity change with a period of 4–5 days in the female mice. To study the mechanism of the action, we
investigated whether ECS could alter the circadian phase but found no influence on the circadian clock system. The potent
and fast-acting efficacy of ECS in the mutant mice supports the predictive validity of the mice as a model of bipolar disorder.
This model will be useful in developing a safe and effective alternative to lithium or electroconvulsive therapy.
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Introduction
Bipolar disorder is a major mental disorder characterized by
recurrent manic and depressive episodes. The involvement of
genetic factors in bipolar disorder has been recognized from twin,
adoption, and family studies [1]. Although linkage analyses and
case-control association studies have been conducted, robustly
replicated loci susceptible to bipolar disorder have not been
identified [2,3]. In this context, several symptom-based animal
models have been reported [4–6]. But such models hardly satisfy
the construct validity; that is, these animals do not mimic aspects
of the etiology.
Our group has focused on a single major gene defect with
pleiotropic effects, one of which manifests bipolar disorder.
Patients with chronic progressive external ophthalmoplegia
(CPEO) are sometimes affected with comorbid mood disorders
[7]. CPEO is a rare disease (MIM 157640) inherited in a
Mendelian fashion. It is characterized by slowly but progressive
ptosis and ophthalmoparesis and is associated with mitochondrial
DNA (mtDNA) aberrations such as deletions, duplications, and
point mutations. Mitochondrial dysfunction in bipolar disorder
has been suggested by magnetic resonance spectroscopy, associ-
ation studies of polymorphisms of mtDNA and nuclear genes
encoding mitochondrial protein, and genome-wide gene expres-
sion analyses [8]. Recently, we generated transgenic mice as a
model of bipolar disorder, in which mutant POLG (mtDNA
polymerase) was expressed in a neuron-specific manner [7]. The
POLG gene is reported to be one of the causative genes for CPEO
comorbid with mood disorders [9].
The transgenic mice (mutPOLG Tg mice) harbor mtDNA
defects in the brains, which show altered activities of serotonin and
noradrenalin. When the mutant animals are subjected to voluntary
wheel running, they show distorted day–night rhythm; they exhibit
continued activity after the light is turned on (delayed activity) and
untimely activity before the light is turned off (anticipatory
activity). In addition, female mutPOLG Tg mice show a robust
periodic activity pattern associated with the estrous cycle. These
behavioral abnormalities are improved by lithium. Therefore, we
propose that mutPOLG Tg mice satisfy the construct, face, and
predictive validities of a model for bipolar disorder [7].
Our group has begun to pursue the cellular pathomechanism of
mutPOLG Tg mice [10], as the model would accelerate
medication development as well as basic research. Prior to
medication development using this model, we focused on
electroconvulsive therapy (ECT) in this study. ECT has long been
used since before the discovery of lithium’s efficacy as a mood-
stabilizing agent, and ECT provides fast-acting relief to depressive
patients and drug-resistant patients [11]. Here we report that
electroconvulsive stimulation (ECS) markedly and immediately
ameliorated the behavioral aberration of mutPOLG Tg mice.
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The effect of ECS on the behavioral phenotypes of
mutPOLG mice
We delivered ECS six times over 2 weeks in the first experiment
(Fig. 1A); this treatment schedule conformed to the standard ECT
regime for patients with mood disorder. ECS seemed to improve
the distorted day–night rhythm of the mutPOLG Tg mice;
however, more than half of the treated mice died after ECS
probably due to respiratory failure, and it became impossible to
statistically analyze the effect of ECS. Therefore, in the second
experiment, mice breathed in oxygen gas for about 1 min before
receiving the electroshock. Oxygenation was highly effective, and
mice rarely died after ECS.
Because effects of ECS were observed within the first week (after
three treatments) in the first experiment, we delivered ECS three
times over 1 week in the second experiment (Fig. 1B). ECS caused
a reduction in wheel-running activity in the night following ECS,
but this returned to the baseline levels after 1 week (Figs. 1B and
2A). Delayed and anticipatory activities, which are indicators of
distorted day–night rhythm, were markedly improved (Fig. 2B and
C). However, the robust periodic activity change observed in
female Tg mice and day-to-day variation in wheel-running
activity, one indicator of the periodic activity change, were not
alleviated by ECS (Figs. 1 and 2D). Both delayed and anticipatory
activities were suppressed for about 1 week after ECS (Fig. 2E),
and some mice subsequently exhibited relapse of the delayed
activity. In contrast, the anticipatory activity was strictly
suppressed until the end of the experiment. ECS did not improve
the robust periodic activity change of the female Tg mice (Fig. 1).
No influence of ECS on the phase of circadian clock
In some cases, ECS-treated mice showed regular day–night
rhythm soon after the first ESC. The immediate effect of ECS
allowed us to assume that ECS induced phase shifts of the circadian
clockandadjustedtheday–nightrhythm.ECSaswellastranscranial
magnetic stimulation induced c-fos mRNA expression in the
suprachiasmatic nucleus (SCN) [12], where the master circadian
clock located. It is also known that c-fos expression is coincident with
light-induced phase-shift of the circadian clock [13,14]. Thus, it
might be possible that ECS improved the phenotype of the mice by
directly affecting the SCN. To test this hypothesis, we examined
whether ECS could alter the phase of circadian clock system.
Animals were transferred and maintained in constant darkness,
resulting in the free-running of circadian clock. Then we delivered a
single ECS under dim red light at various times of day. We observed
no phase shift caused by the ECS at any time of the day (Fig. 3).
Discussion
ECS had a dramatic effect on mutPOLG Tg mice. Delayed and
anticipatory activities, indices of distorted day–night rhythm, were
markedly improved by ECS (Fig. 2B, C and E). This rapid and
potent effect of ECS is quite similar to that of ECT for patients
with mood disorder. ECT is regarded as the most effective
treatment for depression and mania [11]. According to several
reports, patients with bipolar disorder respond more rapidly to
ECT and require fewer treatments than unipolar patients [15,16].
In mutPOLG Tg mice, three treatments of ECS sufficiently
improved both delayed and anticipatory activities. We observed
the wheel-running activity of ECS-treated Tg mice for one month
and found two significant outcomes. First, delayed activity
suppressed by ECS gradually relapsed about 2 weeks afterward
(Fig. 2E, upper), whereas anticipatory activity was completely
suppressed over the 1-month period (Fig. 2E, lower). These
findings suggest that there might be different mechanisms
underlying delayed and anticipatory activities. Second, a robust
activity change associated with the estrous cycle was not improved
by ECS (Figs. 1 and 2D). Since lithium improved the periodic
Figure 1. Wheel-running activity records of representative
mice receiving ECS. Mice were delivered ECS (red triangles) six times
(A) or three times (B). The light and dark periods (12:12 h) are indicated
by white and gray backgrounds, respectively.
doi:10.1371/journal.pone.0001877.g001
A Model for Bipolar Disorder
PLoS ONE | www.plosone.org 2 March 2008 | Volume 3 | Issue 3 | e1877activity change as well as the distorted day–night rhythm [7], we
had hypothesized that the two phenotypes of the mutPOLG mice
were closely related. The present result, however, indicate that
these two phenotypes have different treatment response.
The potent and fast-acting efficacy of ECS in the mutant mice
supports the predictive validity of the mice as a model of bipolar
disorder. Although the molecular mechanism underlying the
actions of lithium and ECT/ECS remains unclear, neurotrophic
growth factors are suggested to be upregulated by lithium [17,18]
and ECS [19–21]. This model will be useful in elucidating the
action mechanism of these medications and also in developing a
safe and effective alternative to lithium or ECT.
Figure 2. Effect of ECS. Mice were oxygenized and delivered ECS three times within a week (days 54, 56, and 58; shown in Fig. 1B).
Wheel-running activity (A), delayed (B) and anticipatory (C) activity indices, and day-to-day variation in activity (D) were estimated on the basis of the
activity levels before (Pre) and after (Post) the treatment (days 11–53 and 66–89, respectively). Values from individual male mice are indicated by
closed circles connected with solid lines, and values from individual female mice are indicated by closed triangles connected with dashed lines.
Delayed activity index of Tg mice and anticipatory activity index of both Tg and non-Tg mice were significantly lowered by ECS. (E) Time courses of
delayed and anticipatory activity indices of male Tg mice receiving ECS. Each color of line represents different individuals (n=9). The week when
three ECS treatments were delivered is indicated by a red background.
doi:10.1371/journal.pone.0001877.g002
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Animals
All the mutant POLG Tg mice used were heterozygotes. Male
mutant mice were used for mating to avoid possible transmission
of mtDNA mutations from the maternal side, although expression
of the transgene is restricted in neuronal tissues. Genomic DNA
was isolated from tail biopsies, and the genotyping was performed
by multiplex PCR using the two sets of primers: Fw, 59-TGG TGA
AAC AGT TGA ATC TTC C-39; Rv, 59-GTC AGG AGA TTG
GTG ATC TGC-39; and Fw, 59-AGT GAG TTG AAA GCC
ATG GTG-39; Rv, 59-GTG GTT GAA CTG CAT CAG TAG
G-39. Controls were non-Tg littermates whenever possible. Mice
of older than 26 weeks of age were used to measure wheel-running
activity, because mtDNA defects were not accumulated in the
young mutPOLG Tg mice [7]. The Wako Animal Experiment
Committee, RIKEN, approved all animal experiment protocols.
Long-term recording of wheel-running activity and
statistic analyses
Recoding and analyses of wheel-running activity were per-
formed as described previously [7]. Wheel-running activity (three
counts per rotation) was recorded every 10 min by an online PC
computer system (O’Hara & Co., Tokyo, Japan).
The delayed activity index is defined as a percent of the activity
during the first 3 h of the light period divided by the total activity
during the previous dark period (12 h). Anticipatory activity index
is defined as a percent of the activity during the last 3 h of the light
period divided by the activity during the following dark period
(12 h). Day-to-day variation in wheel-running activity was
estimated by the unevenness in daily wheel-running activity,
which is the total number of counts of wheel running per day. The
equation used to calculate day-to-day variation was described in
our previous report [7]. Wilcoxon signed-rank tests were used to
test for any difference in these indices before versus after the
treatment. Values of p , 0.05 were considered statistically
significant.
Electroconvulsive stimulation
Animals were handled on the day before the first ECS to
become adjusted to immobilization in a small cylinder and the
application of ear-clip electrodes. Ear-clip electrodes were
dampened with saline and attached to the pinnae, and
electroshock (12–50 mA, 60 pulses/sec, 0.5-msec pulse width, 1-
sec duration) was delivered using an electroconvulsive device (Ugo
Basile, Comerio, Italy) and a bipolar square-wave pulse generator
(Ugo Basile). A tonic seizure was characterized by extension of all
limbs and forward head extension that lasted for about 10 sec. We
titrated the dose (current amplitude) upward in 2-mA steps
beginning at 10–15 mA, which depended on body weight.
Because repeated ECS increased the seizure threshold, we
administered ECS of the last threshold intensity, and we titrated
the intensity upward if the animal did not exhibit a tonic seizure.
Mice were treated 6 times in 2 weeks in the first experiment (male
Tg, n=8; male non-Tg, n=7, 37–48 (44.663.8) weeks old at the
start of recording; female Tg, n=8; and female non-Tg, n=7, 37–
53 (44.365.6) weeks old) and 3 times in 1 week in the second
experiment (male Tg, n=9; male non-Tg, n=6, 32–50 (42.867.1)
weeks old; female Tg, n=8; and female non-Tg, n=2, 26–48
(40.066.8) weeks old). In the second experiment, to prevent death
due to respiratory failure, we placed mice in a plastic bag filled
with oxygen gas for about 1 min before delivering the electro-
shock. The oxygen gas was supplied to mice after ECS until they
began breathing regularly. To investigate the influence of ECS on
the circadian clock, in a third experiment we delivered a single
ECS at various times of day under dim red light. The mice were
placed in constant darkness before delivering ECS. The light
conditions were shown in Fig. 3.
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Figure 3. No influence of ECS on the circadian clock. Double-plotted activity records of representative mice receiving one ECS (red triangles) at
different times of the day: circadian time (CT) 0, 4, 8, 12, 16, and 20. CT0–12 is the subjective light phase, and CT12–24 is the subjective dark phase.
The light and dark periods are indicated by white and gray backgrounds, respectively. Onset of activity shown by green lines was used as the
reference phase for the determination of phase shift.
doi:10.1371/journal.pone.0001877.g003
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